ClinicalTrials.Veeva

Menu

FAECAL MICROBIOTA TRANSPLANTATION IN OBESITY

J

Joint Authority for Päijät-Häme Social and Health Care

Status

Unknown

Conditions

Obesity, Morbid

Treatments

Other: Fecal microbiota transplantation

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

40 patients meeting the criteria for obesity surgery are enrolled. Fecal microbiota transplantation (FMT) will be administered in gastroscopy 6 months before obesity surgery. 20 of the patients will receive a fecal transplant of a thin donor and 20 will receive placebo - a transplant made of their on feces. Changes in weight, laboratory values, general well being and stool microbiota will be measured up to one year after the surgery; one and a half years after FMT. The hypothesis is that FMT and the change in gut microbiota will help to reduce and maintain lower weight.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

• Candidates for the bariatric surgery

BMI ≥ 40 or BMI ≥35 and at least two obesity-related co-morbidities such as type II diabetes (T2DM), hypertension, sleep apnea and other respiratory disorders, non-alcoholic fatty liver disease, osteoarthritis, lipid abnormalities, gastrointestinal disorders, or heart disease.

  • Availability of consecutive fecal samples during one year
  • Compliance to attend gastroscopy and FMT
  • 18-65 years

Exclusion criteria

  • Unable to provide informed consent
  • Pregnancy
  • Type I Diabetes Mellitus
  • Severe renal insufficiency, GFR<30%
  • Chronic or recurrent bacterial infection needing antimicrobial treatment
  • Large hiatal hernia

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

40 participants in 2 patient groups, including a placebo group

Intervention arm
Active Comparator group
Description:
Fecal transplant from a thin donor
Treatment:
Other: Fecal microbiota transplantation
Placebo arm
Placebo Comparator group
Description:
Fecal transplant made from patients own feces
Treatment:
Other: Fecal microbiota transplantation

Trial contacts and locations

2

Loading...

Central trial contact

Perttu Lahtinen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems